Covid-19: Can our vaccine battle new strains? India to check – ET HealthWorld
PUNE: The efficacy of the 2 Indian vaccines presently in use — Covishield and Covaxin — is prone to be examined in opposition to the Brazil and South Africa variants quickly, scientists have mentioned.
The Indian Council of Medical Analysis (ICMR) had introduced on Tuesday that Pune-based Nationwide Institute of Virology was within the strategy of isolating and culturing the South African variant in its lab. The NIV has already readied a tradition of the Brazilian variant for testing.
“Serum samples drawn from those who have received the vaccines in India will be used in the lab to test if they can neutralise the two variants that recently entered India,” mentioned Dr Samiran Panda, head of ICMR’s epidemiology and communicable illnesses division.
The South African variant is often known as 501.V2. The Brazilian one has been tagged as P.1. To this point, India has recorded 4 Covid-positive circumstances with the South African variant and one with the Brazilian variant. “It is not necessary that a variant that is more transmissible will turn out to be more virulent. Another question to ask is whether they are associated with rapidly spreading outbreaks,” mentioned Dr Panda.
Dr Sujeet Kumar Singh, director of Nationwide Centre for Illness Management, mentioned the South African and Brazilian variants have public well being implications.
“For one, the Brazilian variant is believed to be more transmissible and it may have the ability to evade antibodies,” he mentioned. Research present the South African variant too is extra transmissible.Dr Singh didn’t disclose the places within the nation that reported circumstances with the mutated variations.